Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2005 Aug;5(8):655-60.
doi: 10.1038/nri1665.

Two sides of a cellular coin: CD4(+)CD3- cells regulate memory responses and lymph-node organization

Affiliations
Review

Two sides of a cellular coin: CD4(+)CD3- cells regulate memory responses and lymph-node organization

Peter J L Lane et al. Nat Rev Immunol. 2005 Aug.

Abstract

We propose that CD4(+)CD3(-) cells have two functions: a well-established role in organizing lymphoid tissue during development, and a newly discovered role in supporting T-cell help for B cells both during affinity maturation in germinal centres and for memory antibody responses. As CD4(+)CD3(-) cells express the HIV co-receptors CD4 and CXC-chemokine receptor 4, we think that infection of these cells by HIV, and their subsequent destruction by the host immune system, could help to explain the loss of memory antibody responses and the destruction of lymphoid architecture that occur during disease progression to AIDS.

PubMed Disclaimer

Conflict of interest statement

Competing interests statement

The authors declare no competing financial interests.

Figures

Figure 1
Figure 1. Location of adult CD4+CD3CD11cB220 cells
a A digitally processed image of an immunostained section from a mouse spleen is shown, indicating the location of CD4+CD3CD11cB220 cells (red) in relation to CD11c+ dendritic cells (DCs; green) and IgM+ B-cell areas (grey). CD4+CD3 cells are mainly located in the region where the T-cell area and the B-cell follicle adjoin (the B–T interface) and adjacent to follicular T cells in B-cell follicles, whereas DCs are located in T-cell areas and the red pulp. Plasma cells are located in the red pulp, which surrounds the white-pulp areas that contain lymphocytes. This image is reproduced with permission from ref. 2 © (2003) Elsevier. b A schematic version of this image is shown.
Figure 2
Figure 2. CD4+CD3 cells foster the survival of follicular T cells in germinal centres
a In follicles, follicular T (TF) cells drive the proliferation of B cells, which then differentiate into centroblasts and undergo somatic hypermutation of their immunoglobulin variable gene segments. The centroblasts proliferate rapidly and differentiate into centrocytes, which compete for antigen fragments that are trapped at the surface of follicular dendritic cells (FDCs). B-cell mutants that have high-affinity B-cell receptors internalize antigen and present peptide fragments to TF cells, which then provide selective CD40 ligand (CD40L)-dependent rescue signals for B cells. When antigen is scarce, TF cells are sustained by signalling through OX40 and CD30 that is initiated by CD4+CD3 cells, which express OX40 ligand (OX40L) and CD30L constitutively, so that the TF cells can continue to select B cells. Centrocytes that are positively selected leave the germinal centre (GC) and differentiate into memory B cells or mature into long-lived plasma cells. b Before entry to follicles, antigen-specific T cells (white) are primed by dendritic cells (DCs; green) in the T-cell area (white boxes) of lymph nodes. The T cells then upregulate expression of CXC-chemokine receptor 5 (CXCR5) and migrate into B-cell follicles (white arrow). The red box shows an interaction between a TF cell and a CD4+CD3 cell (red) — which allows signalling through OX40 and CD30 in the TF cell — in a B-cell-follicle GC, and the panel on the left shows a high-magnification view of this association. This image is reproduced with permission from ref. 2 © (2003) Elsevier. BCR, B-cell receptor; Fc receptor, receptor for immunoglobulin; TCR, T-cell receptor.
Figure 3
Figure 3. CD4+CD3 cells foster the survival of memory T cells at the B–T interface
a The mechanism for the re-activation of memory T (TM) cells by CD4+CD3 cells is shown. Antigen- specific TM cells that co-express CXC-chemokine receptor 5 (CXCR5) and CC-chemokine receptor 7 (CCR7) migrate across high endothelial venules (HEVs) into lymph nodes, owing to the expression of ligands for peripheral-node addressin (PNAD) by these cells. Interleukin-7 (IL-7) that is produced possibly by stromal cells or follicular dendritic cells (FDCs) in lymphoid tissue upregulates the expression of OX40 at the surface of TM cells. These cells then interact with CD4+CD3 cells, which express OX40 ligand (OX40L) constitutively, in the region where the T-cell area and the B-cell follicle adjoin (the B–T interface). The interaction of CD4+CD3 cells with TM cells provides survival signals to TM cells through OX40, by inducing the upregulation of B-cell lymphoma 2 (BCL-2) and BCL-XL expression. b An image of the B–T interface is shown. The inset shows a high-magnification view of the interaction of a CD4+CD3 cell (red) with a TM cell (white). This image is reproduced with permission from ref. 2 © (2003) Elsevier.

References

    1. Mebius RE. Organogenesis of lymphoid tissues. Nature Rev Immunol. 2003;3:292–303. - PubMed
    1. Kim MY, et al. CD4+CD3− accessory cells costimulate primed CD4 T cells through OX40 and CD30 at sites where T cells collaborate with B cells. Immunity. 2003;18:643–654. - PubMed
    1. Liu YJ, Zhang J, Lane PJ, Chan EY, MacLennan IC. Sites of specific B cell activation in primary and secondary responses to T cell-dependent and T cell-independent antigens. Eur J Immunol. 1991;21:2951–2962. - PubMed
    1. Garside P, et al. Visualization of specific B and T lymphocyte interactions in the lymph node. Science. 1998;281:96–99. - PubMed
    1. Nakano H, Yanagita M, Gunn MD. CD11c+B220+Gr-1+ cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells. J Exp Med. 2001;194:1171–1178. - PMC - PubMed

Publication types